Abstract:An abnormal hormonal activity or exposure to endocrine-disrupting chemicals (EDCs) can cause endocrine system malfunction. Among the many interactions EDCs can affect is the disruption of estrogen signalling, which can lead to adverse health effects such as cancer, osteoporosis, neurodegenerative diseases, cardiovascular disease, insulin resistance, and obesity. Knowing which chemical can act as an EDC is a significant advantage and a practical necessity. New Approach Methodologies (NAM) computational models offer a quick and cost-effective solution for preliminary hazard assessment of chemicals without animal testing. Therefore, a machine learning approach was used to investigate the relationships between estrogen receptor (ER) activity and chemical structure to identify chemicals that can interact with ER. For this purpose, the consolidated in vitro assay data from ToxCast/Tox21 projects was used for developing Random Forest classification models for ER binding, agonists, and antagonists. The overall classification prediction accuracy reaches up to 82%, depending on whether the model predicted agonists, antagonists, or compounds that bind to the active site. Given the imbalance in endocrine disruption data, the derived models are good candidates for deprioritising chemicals and reducing animal testing. The interpretation of theoretical molecular descriptors of the models was consistent with the molecular interactions known in the ligand binding pocket. The estimated class probabilities enabled the analysis of the applicability domain of the developed models and the assessment of the predictions' reliability, followed by the guidelines for interpreting prediction results. The models are openly accessible and useable at QsarDB.org (http://dx.doi.org/10.15152/QDB.259) according to the FAIR (Findable, Accessible, Interoperable, Reusable) principles.

Identification of androgen receptor antagonists: In vitro investigation and classification methodology for flavonoid

QSAR Study of Endocrine Disrupting Chemicals

In silico study on hydroxylated polychlorinated biphenyls as androgen receptor antagonists.

Prenylflavonoids as nonsteroidal phytoestrogens and related structure-activity relationships.

Screening for Aromatase Ligands in the Extract of Broussonetia Papyrifera Using High Performance Liquid Chromatography and ESI-mass Spectrometry

Molecular Docking, Molecular Dynamics Simulation, and Structure-Based 3D-QSAR Studies on the Aryl Hydrocarbon Receptor Agonistic Activity of Hydroxylated Polychlorinated Biphenyls.

Virtual Screening of Potentially Endocrine-Disrupting Chemicals Against Nuclear Receptors and Its Application to Identify PPARγ-bound Fatty Acids

Screening for Ligands of Human Aromatase from Mulberry (mori Alba L.) Leaf by Using High-Performance Liquid Chromatography/tandem Mass Spectrometry

Qualitative and Quantitative Simulation of Androgen Receptor Antagonists: A Case Study of Polybrominated Diphenyl Ethers.

Mechanistic in silico modeling of bisphenols to predict estrogen and glucocorticoid disrupting potentials

Binding of Androgen- and Estrogen-Like Flavonoids to Their Cognate (Non)Nuclear Receptors: A Comparison by Computational Prediction

Evaluation of the binding performance of flavonoids to estrogen receptor alpha by Autodock, Autodock Vina and Surflex-Dock

Three-dimensional quantitative structure activity relationship of flavonoids and estrogen receptor based on docking

Prediction of estrogen receptor binding for 58,000 chemicals using an integrated system of a tree-based model with structural alerts.

Correction to Structures of Endocrine-Disrupting Chemicals Determine Binding to and Activation of the Estrogen Receptor Α and Androgen Receptor

Identification of Estrogen Receptor α Antagonists from Natural Products via In Vitro and In Silico Approaches.

Activation of steroid hormone receptors: Shed light on the in silico evaluation of endocrine disrupting chemicals

Interpretable machine learning for the identification of estrogen receptor agonists, antagonists, and binders

Identifying novel aryl hydrocarbon receptor (AhR) modulators from clinically approved drugs: In silico screening and In vitro validation

Molecular docking and 3D-QSAR-based virtual screening of flavonoids as potential aromatase inhibitors against estrogen-dependent breast cancer

A Ternary Classification Using Machine Learning Methods of Distinct Estrogen Receptor Activities Within A Large Collection of Environmental Chemicals